DiscoverThe Rounds TableEpisode 94 - Top Papers from the 2024 European Society of Cardiology Congress
Episode 94 - Top Papers from the 2024 European Society of Cardiology Congress

Episode 94 - Top Papers from the 2024 European Society of Cardiology Congress

Update: 2024-10-31
Share

Description

Welcome back Rounds Table Listeners!

We are back today with a special Rapid Fire Podcast!

This week, Drs. Mike Fralick and Justin Boyle discuss top papers from the 2024 European of Society of Cardiology Congress. Here we go!

  1. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (0:009:25 ).
  2. Beta-Blocker Interruption or Continuation after Myocardial Infarction (9:2513:52 ).
  3. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (13:5221:20 ).
  4. Continuation vs. Discontinuation of Renin-Angiotensin System Inhibitors Before Major Non-Cardiac Surgery (21:2028:51 ).

Of note, for prescribers in Ontario, there is now a limited use code for finerenone for patients that have both T2DM and CKD. 

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 94 - Top Papers from the 2024 European Society of Cardiology Congress

Episode 94 - Top Papers from the 2024 European Society of Cardiology Congress

Dr. John Fralick and Dr. Michael Fralick